Association study between CAG trinucleotide repeats in the PCQAP gene (PC2 glutamine/Q-rich-associated protein) and schizophrenia

Alessandro De Luca, Emanuela Conti, Nicoletta Grifone, Francesca Amati, Gianfranco Spalletta, Carlo Caltagirone, Giuseppina Bonaviri, Augusto Pasini, Massimo Gennarelli, Bignotti Stefano, Lucia Berti, Gerhard Mittler, Michael Meisterernst, Bruno Dallapiccola, Giuseppe Novelli

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Schizophrenia or schizoaffective disorders are quite common features in patients with DiGeorge/velocardiofacial syndrome (DGS/VCFS) as a result of hemizygosity of chromosome 22q11.2. We evaluated the PCQAP gene, which maps within the DGS/VCFS interval, as a potential candidate for schizophrenia susceptibility. PCQAP encodes for a subunit of the large multiprotein complex PC2, which exhibits a coactivator function in RNA polymerase II mediated transcription. Using a case-control study, we searched association between schizophrenia and the intragenic coding trinucleotide polymorphism. The distribution of the CAG repeat alleles was significantly different between patients and controls with the Mann-Whitney test (z = -2.5694, P = 0.0051; schizophrenics: n = 378, W = 161,002.5, Mean rank = 425.9325; controls: n = 444, W = 177,250.5, Mean rank = 399.2128). This result may indicate a possible involvement of the multiprotein complex PC2 in schizophrenia susceptibility.

Original languageEnglish
Pages (from-to)32-35
Number of pages4
JournalAmerican Journal of Medical Genetics - Neuropsychiatric Genetics
Volume116 B
Issue number1
Publication statusPublished - Jan 1 2003

Fingerprint

Trinucleotide Repeats
Glutamine
Schizophrenia
DiGeorge Syndrome
Multiprotein Complexes
Genes
Proteins
RNA Polymerase II
Psychotic Disorders
Case-Control Studies
Chromosomes
Alleles

Keywords

  • Case-control
  • Coactivator
  • Deletion 22q11
  • DiGeorge syndrome
  • PC2
  • PCQAP
  • Polyglutamine
  • Polymorphism
  • Psychosis
  • Transcription factors
  • Velo-cardio-facial syndrome

ASJC Scopus subject areas

  • Genetics(clinical)
  • Neuropsychology and Physiological Psychology
  • Neuroscience(all)

Cite this

Association study between CAG trinucleotide repeats in the PCQAP gene (PC2 glutamine/Q-rich-associated protein) and schizophrenia. / De Luca, Alessandro; Conti, Emanuela; Grifone, Nicoletta; Amati, Francesca; Spalletta, Gianfranco; Caltagirone, Carlo; Bonaviri, Giuseppina; Pasini, Augusto; Gennarelli, Massimo; Stefano, Bignotti; Berti, Lucia; Mittler, Gerhard; Meisterernst, Michael; Dallapiccola, Bruno; Novelli, Giuseppe.

In: American Journal of Medical Genetics - Neuropsychiatric Genetics, Vol. 116 B, No. 1, 01.01.2003, p. 32-35.

Research output: Contribution to journalArticle

De Luca, Alessandro ; Conti, Emanuela ; Grifone, Nicoletta ; Amati, Francesca ; Spalletta, Gianfranco ; Caltagirone, Carlo ; Bonaviri, Giuseppina ; Pasini, Augusto ; Gennarelli, Massimo ; Stefano, Bignotti ; Berti, Lucia ; Mittler, Gerhard ; Meisterernst, Michael ; Dallapiccola, Bruno ; Novelli, Giuseppe. / Association study between CAG trinucleotide repeats in the PCQAP gene (PC2 glutamine/Q-rich-associated protein) and schizophrenia. In: American Journal of Medical Genetics - Neuropsychiatric Genetics. 2003 ; Vol. 116 B, No. 1. pp. 32-35.
@article{b569dbc1f8184d0798c54937f63e83ca,
title = "Association study between CAG trinucleotide repeats in the PCQAP gene (PC2 glutamine/Q-rich-associated protein) and schizophrenia",
abstract = "Schizophrenia or schizoaffective disorders are quite common features in patients with DiGeorge/velocardiofacial syndrome (DGS/VCFS) as a result of hemizygosity of chromosome 22q11.2. We evaluated the PCQAP gene, which maps within the DGS/VCFS interval, as a potential candidate for schizophrenia susceptibility. PCQAP encodes for a subunit of the large multiprotein complex PC2, which exhibits a coactivator function in RNA polymerase II mediated transcription. Using a case-control study, we searched association between schizophrenia and the intragenic coding trinucleotide polymorphism. The distribution of the CAG repeat alleles was significantly different between patients and controls with the Mann-Whitney test (z = -2.5694, P = 0.0051; schizophrenics: n = 378, W = 161,002.5, Mean rank = 425.9325; controls: n = 444, W = 177,250.5, Mean rank = 399.2128). This result may indicate a possible involvement of the multiprotein complex PC2 in schizophrenia susceptibility.",
keywords = "Case-control, Coactivator, Deletion 22q11, DiGeorge syndrome, PC2, PCQAP, Polyglutamine, Polymorphism, Psychosis, Transcription factors, Velo-cardio-facial syndrome",
author = "{De Luca}, Alessandro and Emanuela Conti and Nicoletta Grifone and Francesca Amati and Gianfranco Spalletta and Carlo Caltagirone and Giuseppina Bonaviri and Augusto Pasini and Massimo Gennarelli and Bignotti Stefano and Lucia Berti and Gerhard Mittler and Michael Meisterernst and Bruno Dallapiccola and Giuseppe Novelli",
year = "2003",
month = "1",
day = "1",
language = "English",
volume = "116 B",
pages = "32--35",
journal = "American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics",
issn = "1552-4841",
publisher = "wiley",
number = "1",

}

TY - JOUR

T1 - Association study between CAG trinucleotide repeats in the PCQAP gene (PC2 glutamine/Q-rich-associated protein) and schizophrenia

AU - De Luca, Alessandro

AU - Conti, Emanuela

AU - Grifone, Nicoletta

AU - Amati, Francesca

AU - Spalletta, Gianfranco

AU - Caltagirone, Carlo

AU - Bonaviri, Giuseppina

AU - Pasini, Augusto

AU - Gennarelli, Massimo

AU - Stefano, Bignotti

AU - Berti, Lucia

AU - Mittler, Gerhard

AU - Meisterernst, Michael

AU - Dallapiccola, Bruno

AU - Novelli, Giuseppe

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Schizophrenia or schizoaffective disorders are quite common features in patients with DiGeorge/velocardiofacial syndrome (DGS/VCFS) as a result of hemizygosity of chromosome 22q11.2. We evaluated the PCQAP gene, which maps within the DGS/VCFS interval, as a potential candidate for schizophrenia susceptibility. PCQAP encodes for a subunit of the large multiprotein complex PC2, which exhibits a coactivator function in RNA polymerase II mediated transcription. Using a case-control study, we searched association between schizophrenia and the intragenic coding trinucleotide polymorphism. The distribution of the CAG repeat alleles was significantly different between patients and controls with the Mann-Whitney test (z = -2.5694, P = 0.0051; schizophrenics: n = 378, W = 161,002.5, Mean rank = 425.9325; controls: n = 444, W = 177,250.5, Mean rank = 399.2128). This result may indicate a possible involvement of the multiprotein complex PC2 in schizophrenia susceptibility.

AB - Schizophrenia or schizoaffective disorders are quite common features in patients with DiGeorge/velocardiofacial syndrome (DGS/VCFS) as a result of hemizygosity of chromosome 22q11.2. We evaluated the PCQAP gene, which maps within the DGS/VCFS interval, as a potential candidate for schizophrenia susceptibility. PCQAP encodes for a subunit of the large multiprotein complex PC2, which exhibits a coactivator function in RNA polymerase II mediated transcription. Using a case-control study, we searched association between schizophrenia and the intragenic coding trinucleotide polymorphism. The distribution of the CAG repeat alleles was significantly different between patients and controls with the Mann-Whitney test (z = -2.5694, P = 0.0051; schizophrenics: n = 378, W = 161,002.5, Mean rank = 425.9325; controls: n = 444, W = 177,250.5, Mean rank = 399.2128). This result may indicate a possible involvement of the multiprotein complex PC2 in schizophrenia susceptibility.

KW - Case-control

KW - Coactivator

KW - Deletion 22q11

KW - DiGeorge syndrome

KW - PC2

KW - PCQAP

KW - Polyglutamine

KW - Polymorphism

KW - Psychosis

KW - Transcription factors

KW - Velo-cardio-facial syndrome

UR - http://www.scopus.com/inward/record.url?scp=0042326309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042326309&partnerID=8YFLogxK

M3 - Article

VL - 116 B

SP - 32

EP - 35

JO - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

JF - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

SN - 1552-4841

IS - 1

ER -